Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor–Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00

PURPOSE: To evaluate the benefit of low-dose cyclophosphamide and methotrexate (CM) maintenance, which previously demonstrated antitumor activity and few adverse effects in advanced breast cancer, in early breast cancer. PATIENTS AND METHODS: International Breast Cancer Study Group (IBCSG) Trial 22-...

Full description

Saved in:
Bibliographic Details
Published in:J Clin Oncol
Main Authors: Colleoni, Marco, Gray, Kathryn P., Gelber, Shari, Láng, István, Thürlimann, Beat, Gianni, Lorenzo, Abdi, Ehtesham A., Gomez, Henry L., Linderholm, Barbro K., Puglisi, Fabio, Tondini, Carlo, Kralidis, Elena, Eniu, Alexandru, Cagossi, Katia, Rauch, Daniel, Chirgwin, Jacquie, Gelber, Richard D., Regan, Meredith M., Coates, Alan S., Price, Karen N., Viale, Giuseppe, Goldhirsch, Aron
Format: Artigo
Language:Inglês
Published: American Society of Clinical Oncology 2016
Subjects:
ORIGINAL REPORTS
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5035120/
https://ncbi.nlm.nih.gov/pubmed/27325862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.65.6595
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items